U.S. FDA authorizes Pfizer/BioNTech booster for 16- and 17-year-olds

Regulators from the U.S. Centers for Disease Control and Prevention (CDC) likely need to sign off on the shots before the teenagers can begin receiving the doses. Around 4.7 million 16- and 17-year-olds in the United States are fully vaccinated and more than 2.5 million of them are six months past their second dose.

from International-News-Economic Times https://ift.tt/3ID1cDW
via IFTTT
SHARE
    Blogger Comment
    Facebook Comment

0 comments:

Post a Comment